Search results
A new COVID variant is dominant in the US: What are its symptoms?
TODAY via Yahoo News· 2 days agoThe new "FLiRT" COVID-19 variants, including KP.3 and KP.2, are spreading in the United States. Will...
COVID-19 is surging. Time to mask up or get a booster? What a Boise medical expert says
Idaho Statesman McClatchy via AOL· 3 days agoBut I’m also very concerned about the fact that we’re not protecting medical staff.” The state...
Novavax (NVAX) Seeks FDA Nod for Updated COVID-19 Vaccine
Zacks via Yahoo Finance· 6 days agoNovavax (NVAX) seeks FDA???s approval to update its COVID-19 vaccine for the 2024-2025 fall season...
CDC data show uptick in COVID-19 cases, low flu activity
Center for Infectious Disease Research and Policy· 2 days agoCOVID test positivity, emergency department visits, hospitalizations, and deaths are are on the...
Billionaire David Tepper Goes Bargain Hunting: 6 Stocks He Just Bought
The Motley Fool via AOL· 2 days agoWhile there is a big bet on tech stocks here, the FXI ETF does contain some state-owned and publicly...
Analysis | How two states reveal a deeper divide on insuring kids’ health
Washington Post· 3 days agoSend your Sunshine State tips to dchang@kff.org. Today’s edition: Democrats are making a push to...
Pfizer Invites Public to View and Listen to Webcast of July 30 Conference Call with Analysts
Morningstar· 5 days agoPfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10:30 a.m. EDT on Tuesday, July 30, 2024. The ...
Biophytis grants Blanver Exclusive Rights to BIO101 in Latin America in Deal Valued at up to €108...
StreetInsider· 4 days ago...Biophytis" or the "Company"), a clinical-stage biotechnology company specialized in thedevelopment oftherapeutics for age-related diseases, today announces the signature of an exclusive license agreement with Blanver, one of the leading and most trusted pharmaceutical company in...
We Won't Solve Long COVID Until We Decide What It Is
Medscape· 6 days agoIs a slow recovery from COVID-19 the lingering effects of a bad infection or the start of a new syndrome?
Ohio lawmakers set to vote on $4.2B capital budget. Where would the money go?
The Columbus Dispatch via Yahoo News· 3 days agoEditor's note: This story has been updated to correct the source of $700 million distributed to...